Pharmacokinetics (PK) of mycophenolate mofetil (MMF) in pediatric allogeneic stem cell transplant (AlloSCT) recipients are associated with significantly higher clearance

被引：0
|
作者：
Militano, O
Roache, K
Shaw, LM
Figurski, M
Satwani, P
Ayello, J
Wolownik, K
Foley, S
Hawkes, R
Del Toro, G
Bradley, MB
George, D
Garvin, J
Bhatia, M
Roman, L
Cairo, MS
机构：
[1] New York Presbyterian, New York, NY USA
[2] Columbia Univ, New York, NY USA
[3] Univ Penn, Med Ctr, Philadelphia, PA 19104 USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1823
引用
收藏
页码：518A / 518A
页数：1
相关论文
共 50 条
  • [41] UNDER-EXPOSURE TO MYCOPHENOLATE ACID (MPA) AFTER REDUCED-INTENSITY CONDITIONING REGIMEN ALLOGENEIC STEM CELL TRANSPLANTATION (RIC ALLOSCT) USING MYCOPHENOLATE MOFETIL (MMF) PLUS CYCLOSPORINE A (CSA) AS GVHD PROPHYLAXIS IS ASSOCIATED TO HIGH RISK OF GRADE
    Martinez, C.
    Millan, O.
    Rovira, M.
    Fernandez-Aviles, F.
    Suarez-Lledo, M.
    Urbano-Ispizua, A.
    Brunet, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S284 - S284
  • [42] Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic stem cell transplantation
    Kasper, C
    Mügge, L
    Schilling, K
    Scholl, S
    Wollina, K
    Höffken, K
    Sayer, H
    BONE MARROW TRANSPLANTATION, 2002, 29 : S187 - S188
  • [43] Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipients
    Kiehl, MG
    Schäfer-Eckart, K
    Kröger, M
    Bornhäuser, M
    Basara, N
    Blau, IW
    Kienast, J
    Fauser, AA
    Ehninger, G
    Armstrong, VW
    Shipkova, M
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (07) : 2922 - 2924
  • [44] A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients
    Osunkwo, I
    Bessmertny, O
    Harrison, L
    Cheung, YK
    Van De Ven, C
    del Toro, G
    Garvin, J
    George, D
    Bradley, MB
    Wolownik, K
    Wischhover, C
    Levy, J
    Skerrett, D
    Cairo, MS
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (04) : 246 - 258
  • [45] INTRAVENOUS (IV) BUSULFAN (BU) ADMINISTERED TWICE DAILY DURING CONDITIONING PRIOR TO ALLOGENEIC STEM CELL TRANSPLANT (ALLOSCT) IN PEDIATRIC RECIPIENTS HAS SIGNIFICANTLY DIFFERENT HALF-LIFE OF ELIMINATION AND CLEARANCE IN RECIPIENTS >4 YEARS AND THOSE ≤4 YEARS
    LeGall, J. B.
    Milone, M.
    Waxman, J.
    Shaw, L.
    Harrison, L.
    Duffy, D.
    van de Ven, C.
    Militano, O.
    Geyer, M.
    Morris, E.
    Lowe, Baxter L.
    Cairo, M. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S304 - S304
  • [46] Risk adapted allogeneic stem cell transplantation (ALLOSCT) for acquired severe aplastic anemia (SAA) in pediatric recipients
    Guerra, J.
    Garvin, J.
    Baldinger, L.
    van de Ven, C.
    Roman, E.
    Bhatia, W.
    Satwani, P.
    Bradley, M. B.
    George, D.
    Schwartz, Y.
    Morris, E.
    Hawkes, R.
    Wolownik, K.
    Foley, S.
    Militano, O.
    Cairo, M. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (02) : 61 - 61
  • [47] Population pharmacokinetics of ciclosporin in allogeneic hematopoietic stem cell transplant recipients: C-reactive protein as a novel covariate for clearance
    Ling, Jing
    Yang, Xu-Ping
    Dong, Lu-Lu
    Jiang, Yan
    Zou, Su-Lan
    Hu, Nan
    Chen, Rong
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (04) : 483 - 492
  • [48] Pharmacokinetics of oral mycophenolate mofetil in combination with CsA in dogs after nonmyeloablative allogeneic hematopoietic stem cell transplantation
    S Lange
    S C Mueller
    S Altmann
    M Dahlhaus
    B Drewelow
    M Freund
    C Junghanss
    Bone Marrow Transplantation, 2008, 41 : 667 - 674
  • [49] Pharmacokinetics-based Optimal Dose-exploration of Mycophenolate Mofetil in Allogeneic Hematopoietic Stem Cell Transplantation
    Yamamori, Motohiro
    Okamura, Atsuo
    Nishikawa, Shinichiro
    Hirai, Midori
    Matsui, Toshimitsu
    THERAPEUTIC DRUG MONITORING, 2009, 31 (05) : 654 - 655
  • [50] Pharmacokinetics of oral mycophenolate mofetil in combination with CsA in dogs after nonmyeloablative allogeneic hematopoietic stem cell transplantation
    Lange, S.
    Mueller, S. C.
    Altmann, S.
    Dahlhaus, M.
    Drewelow, B.
    Freund, M.
    Junghanss, C.
    BONE MARROW TRANSPLANTATION, 2008, 41 (07) : 667 - 674
12345